Abstract
Chronic kidney disease patients frequently exhibit obesity, which not only accelerates progression of their kidney condition but often also poses a hurdle to kidney transplantation. The burgeoning prevalence of obesity has significant renal implications, including escalating risk of and nephrolithiasis irreversible renal failure.
Bariatric surgery, specifically sleeve gastrectomy, stands as a potent stratgy for achieving sustained weight loss. Emerging data advocates its efficacy in ameliorating hypertension, hyperglycemia, and even inciting remission of diabetes.
Research substantiates a decrease in the long-term probability of renal function deterioration and irreversible kidney failure following this surgical intervention. The safety profile of bariatric surgery appears favorable in chronic kidney disease patients, with only a slight elevation in postoperative complications compared to the general population.
Notably, individuals with advanced chronic kidney disease (stages 4 and 5) necessitate special consideration of their distinct metabolic, nutritional, and psychosocial requirements.